A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
Why is my PPI not working?
References
Gastro-oesophageal reflux in adults . In: Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. At: www.tg.org.au
Daniels B, Schaffer A, Buckley NA, et al. The...
One size does not fit all
When it comes to person-centred care, bespoke tailoring to every patient’s healthcare needs is fundamental.
How to deliver respectful, reliable service when dispensing PrEP
When dispensing PrEP medication, it's critical to strike the right balance between a patient's right to privacy and ensuring they have been told everything...
Missed medicine doses: how pharmacists can help
References
Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003;35(3):207.
Brown MT, Bussell JK. Medication adherence: WHO cares?...
Benefits of zinc for preventing and treating the common cold
References
UpToDate. The common cold in adults: Treatment and prevention. 2024. At: www.uptodate.com/contents/the-common-cold-in-adults-treatment-and-prevention?search=the%20common%20cold%20in%20adults&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Pasioti M, Maggina P, Megremis S, et al. The common cold:...
Long-acting treatment for opioid dependence approved
The first long-acting treatment for opioid dependence has been approved for use in Australia by the Therapeutic Goods Administration (TGA).
Buvidal Weekly and Buvidal Monthly...
